FDA Revises Celexa Warnings Over Heart Disorder Risk
Months after warning that high doses of Forest Laboratories Inc.'s antidepressant Celexa could cause a potentially fatal irregular heartbeat, the U.S. Food and Drug Administration announced Wednesday that it had revised...To view the full article, register now.
Already a subscriber? Click here to view full article